Dare Bioscience, Inc. — Director's Dealing 2019

Jan 31, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2019-01-29

Reporting Person: JOHNSON SABRINA MARTUCCI (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-29	Employee Stock Option (right to buy)	$0.759	A	195000	Acquired	2029-01-29	Common Stock (195000)	Direct

Footnotes

F1: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.